Skip to main content

Select Drug Profiles

Original Research, Practice Management

Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients

Suela Sulo, PhD, MSc, Josh Feldstein, BA, Jamie Partridge, PhD, MBA, Bjoern Schwander, MA, RN, Krishnan Sriram, MD, Wm. Thomas Summerfelt, PhD

Suela Sulo, PhD; Josh Feldstein, BA; Jamie Partridge, PhD, MBA; Bjoern Schwander, MS, RN; Krishnan Sriram, MD; Wm. Thomas Summerfelt, PhD

Stakeholder Perspective

The Crucial Role of Nutrition Support Services for Hospitalized Patients

Jack E. Fincham, PhD, RPh

by Jack E. Fincham, PhD, RPh

First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas

First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults

FDA Approvals, In the News

Rituximab Combination Now Approved in 3 Blood Cancers

Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma

Keytruda First Cancer Drug Approved for Any Solid Tumor Based on a Biomarker Instead of Tumor Site

Imfinzi a New PD-L1 Approved for Bladder Cancer After Platinum-Based Chemotherapy

Alunbrig, an Oral Kinase Inhibitor, Receives FDA Approval for NSCLC with ALK Mutation

Rydapt First Drug in Decades Approved by the FDA for Acute Myeloid Leukemia

Stivarga First Drug in a Decade Approved by the FDA for Liver Cancer

Page 85 of 244
Results 841 - 850 of 2438